MINERALOCORTICOID RECEPTOR ANTAGONIST

Clinical trials for MINERALOCORTICOID RECEPTOR ANTAGONIST explained in plain language.

Never miss a new study

Get alerted when new MINERALOCORTICOID RECEPTOR ANTAGONIST trials appear

Sign up with your email to follow new studies for MINERALOCORTICOID RECEPTOR ANTAGONIST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for controlling stubborn hormonal high blood pressure

Disease control Completed

This study tested a new drug called finerenone for people with primary aldosteronism, a common cause of hard-to-treat high blood pressure. The research involved 55 patients to see if finerenone safely lowers blood pressure and protects the heart and kidneys better than current op…

Matched conditions: MINERALOCORTICOID RECEPTOR ANTAGONIST

Phase: PHASE4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

MINERALOCORTICOID RECEPTOR ANTAGONIST

Get alerted when new MINERALOCORTICOID RECEPTOR ANTAGONIST trials appear

New hope for controlling stubborn hormonal high blood pressure